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AbsTrACT
Purpose To evaluate vascular changes in patients with 
intermediate uveitis with or without retinal vasculitis 
using swept-source wide-field optical coherence 
tomography angiography (OCTA).
Methods This is a prospective cross-sectional study. 
Consecutive patients with intermediate uveitis were 
evaluated using wide-field OCTA. Wide-field OCTA and 
en-face OCT images were analysed for the presence of 
capillary non-perfusion and reduced perfusion, disruption 
of ellipsoid zone, and abnormalities on en-face wide-field 
retinal thickness maps, respectively, and compared with 
fluorescein angiography (FA) findings in a subcohort.
results 164 eyes of 88 patients with intermediate 
uveitis were included. Areas of capillary non-perfusion 
and reduced perfusion were more frequently observed 
in the choroidal OCTA slab (33.3% and 49.4%), 
choriocapillaris (CC; 31.4% and 48%) and deep capillary 
plexus (DCP; 9.6% and 34.6%) than in the superficial 
capillary plexus (SCP; 5% and 26.3%), respectively. 
Intermediate uveitis with vasculitis presented more 
frequently with non-perfusion and hypoperfusion in 
the DCP (p=0.003 and p=0.05, respectively) and SCP 
(p=0.007 and p=0.005, respectively) than intermediate 
uveitis without vasculitis. Peripheral capillary leakage 
on FA correlated with the presence of perivascular, 
macular and generalised thickening on en-face wide-
field thickness maps (p=0.007). Ischaemia on FA was 
significantly associated with non-perfusion on wide-
field OCTA in SCP and DCP (p=0.019 and p=0.027, 
respectively).
Conclusion Changes in the choroid, CC and DCP are 
more frequently found than in the SCP on wide-field 
OCTA in intermediate uveitis. While wide-field OCTA 
is a reliable tool to detect capillary non-perfusion in 
intermediate uveitis, it was not helpful in determining 
disease activity.
Trial registration number NCT02811536. 
InTroduCTIon
Intermediate uveitis (IU) is a type of uveitis mainly 
localised to the vitreous and the ciliary body that 
lacks chorioretinal inflammation.1 Concomitant 
retinal vasculitis is often found in this disease, 
involving commonly the peripheral retinal veins.
Fluorescein angiography (FA) is sensitive in the 
diagnosis of retinal vasculitis and also an important 
diagnostic tool to detect macular oedema, optic disc 
oedema and other complications.2 However, FA is 
invasive and has a substantially limited depth reso-
lution; thus, the middle and deeper capillary plexus 
are difficult to visualise.3 Moreover, leakage of dye 
can limit our ability to evaluate adjacent capillary 
perfusion.4 Indocyanine green angiography (ICG) 
allows the assessment of uveitis with choroidal 
involvement. However, the exact localisation of the 
inflammation within the choroid using ICG may be 
challenging.5
Optical coherence tomography angiography 
(OCTA) is a new, non-invasive imaging method that 
provides volumetric data of retinal and choroidal 
layers.6 OCTA has already shown its advantage in 
evaluating foveal microvascular changes in retinal 
vascular diseases as it is able to visualise vascular 
flow in the deep capillary plexus (DCP) as well as 
in the choriocapillaris (CC) and the choroid.6 This 
may be of importance as previous studies could 
illustrate that the deeper vessels rather than the 
superficial vascular plexus are more affected and 
impaired in retinal vascular diseases such as diabetic 
retinopathy.7 Furthermore vascular changes may be 
more easily detected using OCTA compared with 
other imaging modalities.8 Moreover, OCTA can 
provide separate evaluation of abnormalities in the 
retinal and choroidal circulations.9
The wide-field OCTA improves the narrow 
field of view of traditional OCTA. Previous 
studies10 11 have shown that wide-field OCTA 
successfully detected vascular abnormalities seen 
on FA in retinal diseases such as diabetic retinop-
athy and polypoidal choroidal vasculopathy. But 
inherently OCTA cannot detect vascular staining or 
leakage, and its role therefore is somewhat different 
in uveitis than in other vascular disorders domi-
nated by structural changes such as capillary loss 
and others.
The aim of our study is therefore to identify 
and evaluate vascular changes in patients with IU 
with or without retinal vasculitis using wide-field 
OCTA and compare findings with wide-field FA in 
a subcohort.
MeThods
study population
This was a prospective cross-sectional study. 
Consecutive patients presenting with IU with or 
without retinal vasculitis at the Department of 
Ophthalmology of Inselspital, University of Bern, 
between October 2016 and October 2017 were 
enrolled in this study.
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Figure 1 Non-perfusion (white arrow) and reduced perfusion (yellow triangle) in the montage scans. (A) Superficial capillary plexus, (B) deep 
capillary plexus, (C) choriocapillaris and (D) choroid.
Subjects were eligible if the following criteria were met: adult 
patients diagnosed with non-infectious IU with or without 
retinal vasculitis. The diagnosis of IU fulfilled the criteria of 
the Standardization in Uveitis Nomenclature (SUN)12 and the 
disease activity was based on the National Eye Institute (NEI) 
system.13 The diagnosis of retinal vasculitis was based on the 
ophthalmoscopic criteria of a history or presence of intraoc-
ular inflammation, perivascular exudates, intraretinal haemor-
rhage or cotton-wool spots on ophthalmoscopy and evidence 
of vascular occlusion or profound leakage on fluorescein angio-
gram (FA).14 15 Concomitant peripheral vascular sheathing as 
regularly seen in IU was not deemed to be retinal vasculitis. 
Investigational work-up included chest X-ray, QuantiFER-
ON-TB Gold in tube test, serological testing for syphilis and 
Lyme disease, and immunology tests including HLA-B51, anti-
nuclear antibodies, ACE, lysozyme, interleukin-2 receptor and 
antineutrophil cytoplasmic antibodies. Furthermore, an MRI of 
the brain was performed to screen for cerebral vasculitis and 
demyelinating lesions.
Subjects with any ocular condition that would interfere 
with good-quality image acquisition were excluded. Patients 
with history of ocular trauma or other retinal diseases, such as 
diabetic retinopathy, hypertensive retinopathy, central serous 
chorioretinopathy and macular degeneration, and optic nerve 
diseases such as glaucoma or optic neuropathy, were also 
excluded.
Acquisition of oCTA image
All patients underwent ophthalmic examination including 
Snellen best-corrected visual acuity, slit-lamp examination, intra-
ocular pressure and dilated fundus examination. Wide-field FA 
was performed with Heidelberg Spectralis HRA+OCT (Heidel-
berg Engineering, Heidelberg, Germany) using the 102° lens. At 
5 min peripheral sweeps of all quadrants were acquired. If FA 
was not performed on the same day, the most recent FA images 
were compared with OCTA images; in this case, the FAs were 
only included for comparison, if there was no reported change in 
disease activity or therapy and performance of FA was not more 
than 28 days apart from OCTA acquisition. ICG imaging, which 
was typically performed for initial work-up, was also reviewed 
to rule out posterior involvement.
All patients underwent imaging with the swept-source (SS)-
OCT (PLEX Elite 9000; Carl Zeiss Meditec, Dublin, Cali-
fornia). Patients were imaged using wide-field montage OCTA 
scan consisting of five 12×12 mm scans, covering about 
80°–90° of the posterior pole (one centred on the fovea, the 
others centred on the temporal-superior, temporal-inferior, 
nasal-superior and nasal-inferior quadrants; figure 1). The 
individual 12×12 mm scans were reviewed for the presence 
of alignment errors and artefacts due to floaters and manu-
ally corrected if present. After quality check the 12×12 images 
were montaged using the automatic montage export function 
available on the device.
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Figure 2 Disruption (=hyporeflectivity) on the ellipsoid zone of the en-face wide-field slabs. White arrows depict exemplary areas of ellipsoid zone 
disruption.
Figure 3 Example of colour-coded en-face wide-field retinal thickness 
map.
To analyse the individual vascular layers, the custom segmen-
tation of the device was used. The superficial capillary plexus 
(SCP) extends from the internal limiting membrane (ILM) to the 
inner plexiform layer (IPL), and the DCP from the IPL (inner 
boundary) to the outer plexiform layer (outer boundary). The 
CC extends from 29 μm beneath the retinal pigment epitheli-
um(RPE) to 49 μm beneath the RPE, and the choroidal layer has 
a thickness of 51 μm and extends from 64 μm to 115 μm below 
Bruch’s membrane.16
Qualitative analyses of wide-field OCTA images, en-face wide-
field slabs and thickness maps were independently conducted by 
two masked Bern Photographic Reading Center trained readers 
(MT and MRM), at different time-points and in different orders. 
In cases of discrepancies a consensus grading was performed. 
All images were evaluated on the instrument display screen 
in a standardised, dimmed environment. Wide-field montage 
OCTA images were examined for the presence of capillary 
non-perfusion and reduced capillary perfusion in SCP, DCP, 
CC and choroid. Capillary non-perfusion was defined as an 
area of total and profound capillary loss ≥1/4 of the disc area9 
(figure 1). Reduced capillary perfusion referred to smaller areas 
of reduced capillary density (figure 1). The individual struc-
tural OCT B-scans were evaluated for the presence of cystoid 
macualr oedema(CME), epiretinal membrane and disruption of 
the ellipsoid zone. The en-face wide-field slabs were individually 
examined for the presence of disruption of the ellipsoid zone 
(figure 2). The en-face wide-field retinal thickness maps (bound-
aries ILM and RPE; figure 3) were examined for the presence of 
perivascular thickening, macular thickening, peripapillary thick-
ening, generalised thickening and retinal thinning (figure 4). The 
degree of retinal thickness was graded according to the colour-
coded thickness maps. Cool colours (green and blue) represent 
decreased thickness, while warm colours (yellow, orange and 
red) represent increased thickness.17 Qualitative analysis of capil-
lary network abnormalities was then compared with FA. Periph-
eral capillary leakage was compared with flow changes on the 
wide-field OCTA. The 12×12 OCTA scans centred on the optic 
nerve head were carefully reviewed for non-perfusion/hypoper-
fusion and correlated to optic nerve head leakage visible on FA. 
Furthermore, the perfusion abnormalities found on the central 
12×12 scans were correlated to macular leakage. The structural 
OCT B-scans were used to identify epiretinal membrane and . 
CME
statistical analysis
Statistical analysis of the data was performed using SPSS 
V.23.0. Descriptive statistics (percentages, means and SD) were 
computed for demographic and clinical variables. Intergrader 
reproducibility is indicated by Cohen’s kappa. Kappa values up 
to 0.2 indicate a slight agreement, while values between 0.21 
and 0.40 are considered as fair, 0.41–0.60 as moderate, 0.61–
0.80 as substantial and 0.81–1 as almost perfect agreement, 
respectively.18 Phi and Cramer’s V was used for qualitative data 
analysis. A minimal value of p≤0.05 was considered statistically 
significant. P value correction for multiple testing was employed 
using false discovery rate.
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Figure 4 En-face wide-field thickness maps. (A) Normal, (B) macular thickening, (C) peripapillary thickening, (D) perivascular thickening and 
generalised thickening, and (
Table 1 Baseline clinical characteristics
Age (years) 46±19
Sex 
  Male 36 (41.4%)
  Female 51 (58.6%)
Laterality 
  Unilateral 5 (5.7%)
  Bilateral 82 (94.3%)
BCVA (decimal Snellen) 0.9±0.5
Baseline treatment 
  Disease-modifying antirheumatic drugs 45 (51.1%)
Associated systemic disease/aetiology 
  Sarcoidosis 20 (12.2%)
  Latent tuberculosis 8 (4.9%)
  Behçet 24 (14.6%)
  Idiopathic 112 (71.8%)
SS-OCT findings 
  Epiretinal membrane 53 (34%)
  Cystoid macular oedema 28 (18%)
BCVA, best-corrected visual acuity; SS-OCT, swept-source optical coherence 
tomography.
resulTs
One hundred and sixty-four eyes from 88 patients were included 
in this study (mean age 45.5±18.7 years, 54 women [61.4%]). 
One hundred and twenty-four eyes (75.6%) had IU and 40 eyes 
(24.4%) had concomitant retinal vasculitis. The mean Snellen 
acuity was 0.9±0.5 (range: 0.01–1.2). Bilateral disease was 
found in 86%. Thirty-six eyes (22%) exhibited clinically active 
inflammation based on the SUN/NEI criteria. Forty-five patients 
(51.1%) were on systemic conventional synthetic or biological 
disease-modifying antirheumatic drugs.
Eight eyes were retrospectively excluded from the analysis 
because of poor OCTA image quality. Thus, 156 (95.1%) eyes, 
including 120 (76.9%) with IU and 36 (23.1%) with concom-
itant vasculitis, were evaluated. Out of these, 11 eyes have no 
FA images available. The intergrader agreement was substantial 
to almost perfect, ranging from 0.69 to 0.85 (Cohen’s kappa). 
Online supplementary table 1 summarises the results of inter-
grader agreements for each individual evaluated parameter. 
Baseline clinical characteristics, FA and SS-OCT findings are 
summarised in table 1.
en-face oCT wide-field findings
The en-face wide-field thickness maps (figure 4) are summarised 
in table 2.
There was an association between peripheral capillary leakage 
on FA and the presence of perivascular, macular and generalised 
thickening on en-face wide-field thickness maps (p=0.007, 
corrected [corr] p=0.04), but there was no significant correla-
tion between clinically assessed disease activity and the findings 
on wide-field thickness map. Disruption of the ellipsoid zone 
was visible in 36 eyes (23.1%) on the en-face wide-field slabs 
(figure 2), which was associated with the presence of CME 
(p≤0.0001, corr p=0.03) and ERM (p≤0.0001, corr p=0.03).
Characteristics of eyes with Iu with/without retinal vasculitis 
on wide-field oCTA
Table 3 summarises the prevalence of capillary non-perfusion 
and reduced capillary perfusion on wide-field OCTA (figure 1) 
of eyes with IU with and without vasculitis in the individual 
customised retinal and choroidal slabs.
In general, capillary non-perfusion and reduced perfusion 
were more frequently observed in the choroid, CC and DCP than 
in the SCP (table 3). This high prevalence of CC and choroidal 
reduced perfusion seems noteworthy given that only five eyes 
(3.2%) showed an area of obvious chorioretinal atrophy, which 
was always unrelated to underlying IU. While IU with vasculitis 
presented more frequently with non-perfusion and hypoper-
fusion in the DCP (p=0.003, corr p=0.04 and p=0.05, corr 
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Table 2 Findings on the en-face wide-field thickness maps
en-face wide-field thickness maps Prevalence (%)
Perivascular thickening 10 (6.4)
Macular thickening 36 (23.1)
Peripapillary thickening 26 (16.7)
Generalised thickening 11 (7.1)
Retinal thinning 12 (7.7)
Table 3 Capillary non-perfusion and capillary reduced perfusion in SCP, DCP, CC and choroid
Intermediate uveitis without vasculitis Intermediate uveitis with concomitant retinal vasculitis
non-perfusion reduced perfusion non-perfusion reduced perfusion
Montage wide-field scans 
  SCP 3 (2.5%) 25 (20.8%) 5 (13.9%) 16 (44.4%)
  DCP 7 (5.8%) 37 (30.8%) 8 (22.2%) 17 (47.2%)
  CC 36 (30%) 57 (47.5%) 13 (36.1%) 18 (50%)
  Choroid 36 (30%) 57 (47.5%) 16 (44.4%) 20 (55.6%)
Peripapillary area 
  SCP 1 (0.8%) 14 (11.7%) 0 (0%) 6 (16.7%)
  DCP 2 (1.7%) 13 (10.8%) 0 (0%) 7 (19.4%)
  CC 5 (4.2%) 12 (10%) 5 (13.9%) 12 (33.3%)
  Choroid 7 (5.8%) 16 (13.3%) 3 (8.3%) 12 (33.3%)
CC, choriocapillaris; DCP, deep capillary plexus; SCP, superficial capillary plexus.
Table 4A The wide-field FA findings in the subcohort compared 
with wide-field OCTA
Wide-field FA findings Prevalence (%)
Peripheral capillary leakage 36 (76.6)
Peripheral capillary dropout 13 (27.7)
Hot disc 15 (31.9)
Macular leakage 22 (46.8)
FA, fluorescein angiography; OCTA, optical coherence tomography angiography.
p=0.2, respectively) and SCP (p=0.007, corr p=0.04 and 
p=0.005, corr p=0.04, respectively) than IU without vasculitis, 
there was no significant difference in terms of non-perfusion 
and hypoperfusion in the CC (p=0.48, corr p=0.7 and p=0.79, 
corr p=0.87, respectively) or choroid between those two patient 
groups (p=0.1, corr p=0.46 and p=0.4, corr p=0.7, respec-
tively) (table 3). There was no significant difference in capillary 
non-perfusion or reduced perfusion in the SCP (p=0.5, corr 
p=0.7 and p=0.9, corr p=0.93, respectively) or DCP wide-field 
slabs (p=0.6, corr p=0.74 and p=0.2, corr p=0.6, respectively) 
between active and inactive eyes.
Comparisons between oCTA and FA findings
There were 47 cases with comparable FAs with a mean period 
between OCTA and FA of 10.7±14.7 days. Details can be found 
in table 4A and B. Table 4A and B Comparison of wide-field FA 
findings and wide-field OCTA findings.
There was no association between peripheral capillary leakage 
on FA and non-perfusion or reduced peripheral perfusion on 
wide-field OCTA in the SCP (p=0.36, corr p=0.7 and p=0.88, 
corr p=0.93, respectively), DCP (p=0.94, corr p=0.94 and 
p=0.7, corr p=0.83, respectively), CC (p=0.5, corr p=0.7 and 
p=0.22, corr p=0.6, respectively) or choroid (p=0.47, corr 
p=0.7 and p=0.59, corr p=0.74, respectively). However, capil-
lary dropout and ischaemia visible in 27.7% on FA was asso-
ciated with capillary non-perfusion on wide-field OCTA in the 
SCP and DCP, respectively (p=0.019, corr p=0.1 and p=0.027, 
corr p=0.12, respectively), but missed statistical significance 
after p value correction. Considering FA as gold standard, the 
sensitivity and specificity in the detection of capillary dropout 
in the SCP on OCTA were 15% and 97%, respectively (false 
negative rate=85%, false positive rate=3%). The sensitivity and 
specificity in the detection of capillary dropout in the DCP were 
24% and 94%, respectively. Peripheral capillary non-perfusion 
or hypoperfusion of the CC and choroid was not associated with 
capillary dropout on FA (CC: p=0.39, corr p=0.7 and p=0.4, 
corr p=0.7; choroid: p=0.58, corr p=0.74 and p=0.31, corr 
p=0.7, respectively). Peripapillary capillary non-perfusion or 
hypoperfusion in the SCP (p=0.49, corr p=0.7 and p=0.7, corr 
p=0.84), DCP (p=0.49, corr p=0.7 and p=0.13, corr p=0.46), 
CC (p=0.75, corr p=0.86 and p=0.49, corr p=0.7) and choroid 
(p=0.22, corr p=0.58 and p=0.5, corr p=0.7) was not associ-
ated with the presence of a hot disc. Also macular leakage on FA 
was not associated with non-perfusion or hypoperfusion on the 
central OCTA slabs.
dIsCussIon
We here present a prospective cross-sectional study using wide-
field SS-OCTA images to evaluate vascular changes in patients 
with IU with or without retinal vasculitis. Our paper evaluated 
vascular changes using wide-field OCTA in IU and retinal vascu-
litis as previous uveitis studies have focused on vascular changes 
on the central 3×3 mm OCTA scans.19 20 Our data show that 
montage wide-field OCTA seems to be a promising tool to detect 
microvascular alterations of the retina and choroid. Thus, flow 
void within 80°–90° can be directly seen and may not be indi-
rectly evaluated using a central 3×3 or 6×6 scan. In contrast to 
FA, where the assessment of the capillary plexus is limited due 
to the trilaminar pattern of the network by leakage and by poor 
resolution of the DCP,3 20 OCTA can individually visualise the 
peripapillary plexus, the DCP, the CC and the choroid.
Qualitatively on the wide-field OCTA, the DCP was more 
frequently involved than the SCP. This is in line with the find-
ings of previous studies12–14 19 on retinal diseases such as vein 
occlusion and diabetic retinopathy, in which more profound 
alterations have also been observed in the DCP than in the SCP. 
The reason for this may be that, unlike the superficial retinal 
capillaries, the deep capillaries are not directly connected to 
arterioles, and are therefore more vulnerable to ischaemia.21 A 
previous paper by Spaide22 investigated the microvascular flow 
abnormalities associated with retinal vasculitis in areas of active  o
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Table 4b The wide-field OCTA findings in the subcohort compared 
with wide-field FA
Capillary non-perfusion Capillary reduced perfusion
Wide-field OCTA findings 
  SCP 2 (4.3%) 12 (25.5%)
  DCP 4 (8.5%) 15 (31.9%)
  CC 15 (31.9%) 23 (48.9%)
  Choroid 16 (34%) 22 (46.8%)
Peripapillary area 
  SCP 1 (2.1%) 8 (17%)
  DCP 1 (2.1%) 9 (19.1%)
  CC 4 (8.5%) 9 (19.1%)
  Choroid 3 (6.4%) 9 (19.1%)
CC, choriocapillaris; DCP, deep capillary plexus; FA, fluorescein angiography; OCTA, 
optical coherence tomography angiography; SCP, superficial capillary plexus.
vasculitis. Similar to our results, he found qualitatively larger 
areas of absent flow in the DCP compared with the SCP.22
Although wide-field OCTA seems a promising additional tool 
for the assessment of peripheral retinal ischaemia, it currently 
has limited potential to fully replace wide-field FA. Although the 
prevalence of reduced capillary perfusion found on the wide-
field OCTA in the SCP was similar to the prevalence of capillary 
non-perfusion on wide-field FA, the association of this finding 
between FA and OCTA did not remain statistically significant 
after p value correction. And although the specificity for the 
detection of capillary non-perfusion on OCTA was high, the 
sensitivity was rather low. However, our assessment was qual-
itative and a 12×12 scan pattern with a lower resolution of 24 
µm was used. Previous studies could show that OCTA may be 
even more sensitive than FA in detecting perifoveal capillary 
abnormalities, such as hypoperfusion and non-perfusion on the 
ocular sarcoidosis eyes and retinal vasculitis,23 24 and a recent 
report illustrated that wide-field OCTA depicts the extensive 
capillary non-perfusion of the peripheral retina better than FA in 
some retinal vasculitis cases.25 Thus, with the progress of OCTA 
in terms of acquisition time and resolution, wide-field OCTA 
may soon become a sensitive and quantitative tool for the direct 
assessment of peripheral capillary dropout of the individual 
retinal and choroidal vascular layers.
Interestingly, although none of the OCTA data showed an 
association with peripheral capillary leakage on FA, there was a 
correlation between peripheral capillary leakage on FA and peri-
vascular-peripapillary and macular thickening on en-face wide-
field thickness maps. In keeping, a previous study on patients 
with Birdshot chorioretinopathy has shown that perivascular 
thickening on thickness maps corresponds to vasculitis and may 
be used to follow phlebitis and disease activity in patients with 
respective disease.17 Our findings broaden the spectrum of eval-
uable diseases, which makes en-face thickness maps a promising, 
additional tool to follow patients with uveitis.
A surprisingly high percentage of patients had some CC and 
choroidal flow void. In some cases, alterations of the choroidal 
circulation were explainable by the presence of peripapil-
lary chorioretinal atrophy or chorioretinal atrophy elsewhere; 
however, in the majority of eyes, decreased flow was indepen-
dent of respective finding. Although several studies evaluated 
the choroidal involvement using OCTA in posterior uveitis,4 26 27 
nothing is so far known about the choroidal involvement in 
patients with IU using OCTA. In a recent paper, Wintergerst and 
coauthors28 quantitatively analysed the CC perfusion in central 
3×3 mm OCTA scans and also revealed that altered CC perfusion 
is frequently present in IU. The choroidal blood supply is still 
poorly understood. Anatomical postmortem studies describe 
the CC and choroid as highly anastomosed network, while in 
vivo studies indicate an end-arterial circulation.29 Whether IU 
and vasculitis without visible posterior involvement may cause 
indirect decrease in flow signal or a blockage phenomenon due 
to inflammation of the CC and choroid needs definitely further 
evaluations. Recent studies on healthy eyes quantified CC flow 
void and found an age-dependent decrease of CC in healthy 
subjects (oral presentation IRIS, Los Angeles, 2018; and OCT 
and Retina forum, Milan, 2018).30 It may be therefore possible 
that inflammation in the eye exaggerates the normal age-depen-
dent decrease of CC and choroidal flow.
The inclusion of both eyes to increase the number of observa-
tions must be considered as potential limitation, as it may have 
biased our results. Overall, based on all the findings, we can 
conclude that OCTA is a valuable imaging modality to assess 
peripheral capillary non-perfusion in patients with IU with or 
without vasculitis and enables the evaluation of the perfusion 
status of the SCP, DCP, CC and choroid of about 80°−90°.
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